NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »
COPENHAGEN, Denmark, Aug. 31, 2020 /PRNewswire/ — H. Lundbeck A/S (Lundbeck) today announced headline results …
Read More »
SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
Intrexon Corporation and its oncology partner Ziopharm Oncology have entered an immunotherapy deal with MD …
Read More »
Merck and Bristol-Myers Squibb continue to their race in immuno-oncology, a popular research area. On …
Read More »
Dublin-based Shire has agreed to use its AbbVie breakup fee to acquire rare disease drugmaker …
Read More »
Argos Therapeutics Inc.’s experimental HIV immunotherapy failed its mid-stage trial. The company announced today that …
Read More »
Incyte and Agenus will partner on immuno-oncology targets in a deal worth up to $410 …
Read More »
As 2015 arrives, it is wonderful to kick off the first blog of the new …
Read More »
Biogen Idec said that its experimental multiple sclerosis (MS) drug showed signs that it could …
Read More »
ASCO submitted comments Jan. 5 to the House Committee on Energy and Commerce, Health Subcommittee, …
Read More »
Gilead Sciences Inc.’s shares were up more than two percent Monday following news that the …
Read More »
A panel of advisors for the US Food and Drug Administration (FDA) has recommended approval …
Read More »
Today, Pfizer Inc. announced that it is in discussion with the US Food and Drug …
Read More »
Pharmaceuticals Incorporated recently announced that US health regulators approved a supplemental new drug application (sNDA) …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
